ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 178 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $46,009 | -36.2% | 14,514 | 0.0% | 0.00% | – |
Q2 2023 | $72,135 | +0.6% | 14,514 | 0.0% | 0.00% | – |
Q1 2023 | $71,699 | -21.5% | 14,514 | 0.0% | 0.00% | – |
Q4 2022 | $91,293 | -27.0% | 14,514 | +25.3% | 0.00% | -100.0% |
Q3 2022 | $125,000 | -5.3% | 11,586 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $132,000 | +24.5% | 11,586 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $106,000 | -38.7% | 11,586 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $173,000 | -23.5% | 11,586 | +31.6% | 0.00% | 0.0% |
Q3 2021 | $226,000 | +29.9% | 8,802 | +32.2% | 0.00% | 0.0% |
Q2 2021 | $174,000 | -26.0% | 6,658 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $235,000 | +5.4% | 6,658 | -24.7% | 0.00% | 0.0% |
Q4 2020 | $223,000 | -3.9% | 8,838 | +43.5% | 0.00% | -50.0% |
Q3 2020 | $232,000 | -12.1% | 6,161 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $264,000 | +461.7% | 6,161 | +156.1% | 0.00% | – |
Q1 2020 | $47,000 | -25.4% | 2,406 | 0.0% | 0.00% | – |
Q4 2019 | $63,000 | -4.5% | 2,406 | 0.0% | 0.00% | -100.0% |
Q3 2019 | $66,000 | +1.5% | 2,406 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $65,000 | – | 2,406 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vida Ventures Advisors, LLC | 1,798,163 | $5,700,177 | 8.82% |
Wildcat Capital Management, LLC | 1,920,787 | $6,088,895 | 2.44% |
TPG GP A, LLC | 18,716,306 | $59,330,690 | 1.02% |
EcoR1 Capital, LLC | 4,488,200 | $14,227,594 | 0.48% |
CROSSPOINT FINANCIAL, LLC | 12,000 | $38,040 | 0.40% |
Coastal Bridge Advisors, LLC | 406,847 | $1,289,705 | 0.35% |
CAXTON ASSOCIATES LP | 480,104 | $1,521,930 | 0.21% |
Woodline Partners LP | 5,313,915 | $16,845,111 | 0.20% |
Rhenman & Partners Asset Management AB | 300,000 | $951,000 | 0.10% |
Navalign, LLC | 75,365 | $238,907 | 0.09% |